Patent holdings for IPC class C07C 309/30

Total number of patents in this class: 280

10-year publication summary

24
22
30
26
30
32
15
19
19
9
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Intra-Cellular Therapies, Inc.
437
12
Journey Medical Corporation
99
9
Merck Sharp & Dohme LLC
3737
7
Assia Chemical Industries Ltd.
241
6
WisTa Laboratories Ltd.
119
6
BASF SE
21306
5
Shin-Etsu Chemical Co., Ltd.
6120
5
ChemoCentryx, Inc.
361
5
Gilead Sciences, Inc.
2236
5
Imago Biosciences, Inc.
39
5
Purdue Pharma L.P.
433
5
Shionogi & Co., Ltd.
883
5
Eidos Therapeutics, Inc.
21
5
Advansix Resins & Chemicals LLC
307
4
Lantheus Medical Imaging, Inc.
165
4
Pharmatrophix, Inc.
25
4
Bristol-myers Squibb Company
4757
3
Uop LLC
4390
3
Chevron Oronite Company LLC
598
3
Apotex Inc.
203
3
Other owners 176